Offer - Urjas Oil for just ₹ 1 X
Vogipax Mp 500 Mg/7.5 Mg/0.2 Mg Tablet (10) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Vogipax Mp 500 Mg/7.5 Mg/0.2 Mg Tablet (10) safe for pregnant women?
Pregnant women may get severe side effects after taking Vogipax Mp. If you are pregnant, do not take Vogipax Mp without a doctor's advice.
Is the use of Vogipax Mp 500 Mg/7.5 Mg/0.2 Mg Tablet (10) safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Vogipax Mp. So it is adviced to consult the doctor before using it.
What is the effect of Vogipax Mp 500 Mg/7.5 Mg/0.2 Mg Tablet (10) on the Kidneys?
Vogipax Mp rarely affects the kidneys.
What is the effect of Vogipax Mp 500 Mg/7.5 Mg/0.2 Mg Tablet (10) on the Liver?
Use of Vogipax Mp may be dangerous for the liver. Do not use it without doctor's advice.
What is the effect of Vogipax Mp 500 Mg/7.5 Mg/0.2 Mg Tablet (10) on the Heart?
Vogipax Mp has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Vogipax Mp 500 Mg/7.5 Mg/0.2 Mg Tablet (10) unless your doctor advises you to do so -
Is this Vogipax Mp 500 Mg/7.5 Mg/0.2 Mg Tablet (10) habit forming or addictive?
No, there is no any evidence that Vogipax Mp 500 Mg/7.5 Mg/0.2 Mg Tablet (10) is addictive.
Interaction between Food and Vogipax Mp 500 Mg/7.5 Mg/0.2 Mg Tablet (10)
There is no information on the effects of taking Vogipax Mp 500 Mg/7.5 Mg/0.2 Mg Tablet (10) with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Vogipax Mp 500 Mg/7.5 Mg/0.2 Mg Tablet (10)
It is difficult to say anything about the effect of Vogipax Mp 500 Mg/7.5 Mg/0.2 Mg Tablet (10) and alcohol. No research has been done on this yet.
Yes, you can take Vogipax Mp with gliclazide, no harmful interactions have been reported between them. However, it is not necessary that no interaction can happen between these two. But before taking such kind of combination you must consult your doctor.
Yes, Vogipax Mp can cause night sweat, the exact mechanism of sweating is not known. But some research suggests that Vogipax Mp causes hypoglycemia (low blood sugar) especially at night which can cause night sweats. Need to monitor your blood glucose level regularly, and talk to your doctor as your dose of Vogipax Mp may need to be adjusted.
Vogipax Mp is not a known cause of alopecia (hair loss). However, the conditions treated by Vogipax Mp type 2 diabetes and PCOS, often list hair loss as a possible symptom.
The long-term use can lead to the deficiency of Vitamin B12, which can further lead to megaloblastic anemia. Furthermore, Long-term Metformin use can also lead to kidney and liver problems.
Yes, Vogipax Mp commonly cause stomach upset like diarrhea, abdominal pain, nausea, and vomiting. To avoid these side effects you should take Vogipax Mp with your meal and increase the dose gradually.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277